| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Orahealth USA is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BeBetter Networks, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Charleston, WV. To find more information about BeBetter Networks, Inc., please visit www.bebetter.net
http://www.pinterest.com/infinitetherap/boards/
Medrobotics Corporation manufactures and markets the Flex® System, a robot-assisted platform that provides single-site access and visualization of hard-to-reach anatomical locations and the Flex® Retractor, a low profile, fully adjustable transoral retractor that accommodates advanced surgical systems.